Total Payments
$2,050
2023 Payments
$497.35
Companies
7
Transactions
126
Medicare Patients
1,513
Medicare Billing
$153,021
Payment Breakdown by Category
Food & Beverage$2,050 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,050 | 126 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $910.72 | 46 | $0 (2023) |
| ABBVIE INC. | $331.89 | 25 | $0 (2023) |
| Janssen Biotech, Inc. | $324.02 | 26 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $178.57 | 12 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $148.29 | 10 | $0 (2023) |
| Acacia Pharma Inc | $105.97 | 4 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $50.32 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $497.35 | 27 | Takeda Pharmaceuticals U.S.A., Inc. ($266.61) |
| 2022 | $1,094 | 76 | Takeda Pharmaceuticals U.S.A., Inc. ($343.52) |
| 2021 | $458.49 | 23 | Takeda Pharmaceuticals U.S.A., Inc. ($300.59) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/08/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/10/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/28/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/22/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 06/15/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: IMMUNOLOGY | ||||||
| 06/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/17/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 05/17/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Immunology | ||||||
| 05/16/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/02/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/19/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Immunology | ||||||
| 04/18/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/13/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Immunology | ||||||
| 04/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/06/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/30/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/23/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 03/03/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Immunology | ||||||
| 02/22/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Gastroenterology | ||||||
| 02/15/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 02/08/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/06/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/02/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: IMMUNOLOGY | ||||||
| 01/23/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 305 | 308 | $276,917 | $29,747 |
| 2022 | 4 | 433 | 436 | $423,000 | $44,483 |
| 2021 | 4 | 419 | 422 | $372,285 | $42,573 |
| 2020 | 4 | 356 | 359 | $271,358 | $36,219 |
Total Patients
1,513
Total Services
1,525
Medicare Billing
$153,021
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2023 | 112 | 113 | $105,124 | $10,818 | 10.3% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2023 | 78 | 80 | $71,518 | $7,299 | 10.2% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2023 | 68 | 68 | $49,016 | $6,572 | 13.4% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2023 | 47 | 47 | $51,259 | $5,058 | 9.9% |
| 00811 | Anesthesia for other procedure on large bowel using an endoscope | Facility | 2022 | 163 | 163 | $158,250 | $16,033 | 10.1% |
| 00731 | Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | Facility | 2022 | 108 | 111 | $109,350 | $11,030 | 10.1% |
| 00812 | Anesthesia for exam of colon using an endoscope | Facility | 2022 | 93 | 93 | $72,450 | $9,073 | 12.5% |
| 00813 | Anesthesia for procedure on small and large bowel using an endoscope | Facility | 2022 | 69 | 69 | $82,950 | $8,347 | 10.1% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2021 | 175 | 175 | $150,935 | $16,599 | 11.0% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 118 | 121 | $109,316 | $12,136 | 11.1% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2021 | 76 | 76 | $56,538 | $7,626 | 13.5% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2021 | 50 | 50 | $55,496 | $6,212 | 11.2% |
| 00811 | Anesthesia for procedure on large bowel using an endoscope | Facility | 2020 | 180 | 180 | $137,064 | $18,065 | 13.2% |
| 00731 | Anesthesia for procedure on esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 109 | 111 | $84,683 | $10,881 | 12.8% |
| 00812 | Anesthesia for diagnostic examination of large bowel using an endoscope | Facility | 2020 | 39 | 40 | $23,382 | $3,894 | 16.7% |
| 00813 | Anesthesia for procedure on esophagus, stomach, small bowel, and/or large bowel using an endoscope | Facility | 2020 | 28 | 28 | $26,229 | $3,379 | 12.9% |
About Ricardo Sigala, CRNA
Ricardo Sigala, CRNA is a Nurse Anesthetist, Certified Registered healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2015. The National Provider Identifier (NPI) number assigned to this provider is 1609265867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ricardo Sigala, CRNA has received a total of $2,050 in payments from pharmaceutical and medical device companies, with $497.35 received in 2023. These payments were reported across 126 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($2,050).
As a Medicare-enrolled provider, Sigala has provided services to 1,513 Medicare beneficiaries, totaling 1,525 services with total Medicare billing of $153,021. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Anesthetist, Certified Registered
- Other Specialties Certified Registered|Registered Nurse
- Location Lubbock, TX
- Active Since 01/12/2015
- Last Updated 08/08/2016
- Taxonomy Code 367500000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609265867
Products in Payments
- ENTYVIO (Biological) $649.64
- STELARA (Biological) $202.11
- XIFAXAN (Drug) $178.57
- SKYRIZI (Biological) $150.61
- OCALIVA (Drug) $148.29
- GATTEX (Drug) $130.13
- REMICADE (Biological) $121.91
- BYFAVO (Drug) $105.97
- RINVOQ (Biological) $105.40
- HUMIRA (Biological) $75.88
- MOTEGRITY (Drug) $59.04
- DUPIXENT (Biological) $50.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Anesthetist, Certified Registered Doctors in Lubbock
Paul Wolff
Nurse Anesthetist, Certified Registered — Payments: $945.62
Nurse Anesthetist, Certified Registered $945.62
Chad Edwards
Nurse Anesthetist, Certified Registered — Payments: $921.74
Nurse Anesthetist, Certified Registered $921.74
Sabino Lopez, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $678.08
Nurse Anesthetist, Certified Registered $678.08
Natalie Sell, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $664.57
Nurse Anesthetist, Certified Registered $664.57
Helen Avalos, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $513.49
Nurse Anesthetist, Certified Registered $513.49
Ms. Emma Veld, Crna, CRNA
Nurse Anesthetist, Certified Registered — Payments: $486.14
Nurse Anesthetist, Certified Registered $486.14